| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0731-7085(03)00576-4 |
| P698 | PubMed publication ID | 15127807 |
| P2093 | author name string | Fei Tan | |
| Xianhong Wen | |||
| Zhijun Jing | |||
| Ziuyang Liu | |||
| P2860 | cites work | Improvement of the in vitro dissolution of praziquantel by complexation with alpha-, beta- and gamma-cyclodextrins | Q30559082 |
| Carvedilol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders | Q41521300 | ||
| Molecular modeling study of beta- and gamma-cyclodextrin complexes with miconazole | Q43625290 | ||
| Study on the inclusion complexes of bromazepam with beta- and beta-hydroxypropyl-cyclodextrins | Q43991510 | ||
| Preparation and study on the solid inclusion complex of sparfloxacin with HP-beta-cyclodextrin | Q44332422 | ||
| Thermodynamic study on the effects of beta-cyclodextrin inclusion with anilinonaphthalenesulfonates | Q44683185 | ||
| Cyclodextrin Drug Carrier Systems | Q60305154 | ||
| Interactions of ketoprofen and ibuprofen with β-cyclodextrins in solution and in the solid state | Q63379412 | ||
| Spectrofluorimetric determination of piroxicam in the presence and absence of beta-cyclodextrin | Q73291441 | ||
| Complexation study of diclofenac with beta-cyclodextrin and spectrofluorimetric determination | Q73620904 | ||
| Applications of Computational Chemistry to the Study of Cyclodextrins | Q77646764 | ||
| P433 | issue | 3 | |
| P921 | main subject | carvedilol | Q412534 |
| P304 | page(s) | 517-523 | |
| P577 | publication date | 2004-02-01 | |
| P1433 | published in | Journal of Pharmaceutical and Biomedical Analysis | Q15752537 |
| P1476 | title | Preparation and study the 1:2 inclusion complex of carvedilol with beta-cyclodextrin | |
| P478 | volume | 34 |
| Q46871574 | 1H and 13C NMR characteristics of β-blockers |
| Q35577222 | Advanced technologies for oral controlled release: cyclodextrins for oral controlled release. |
| Q41975966 | Aripiprazole-cyclodextrin binary systems for dissolution enhancement: effect of preparation technique, cyclodextrin type and molar ratio |
| Q35957617 | Carvedilol nano lipid carriers: formulation, characterization and in-vivo evaluation |
| Q42374191 | Carvedilol: solubilization and cyclodextrin complexation: a technical note |
| Q39769144 | Characterization of solid dispersions of itraconazole and vitamin E TPGS prepared by microwave technology |
| Q41500018 | Comparative study on the effects of some polyoxyethylene alkyl ether and sorbitan fatty acid ester surfactants on the performance of transdermal carvedilol proniosomal gel using experimental design |
| Q57439929 | Cyclodextrin facilitated electrospun chitosan nanofibers |
| Q41885580 | Drug solubility: importance and enhancement techniques |
| Q30459146 | Fabrication of carvedilol nanosuspensions through the anti-solvent precipitation-ultrasonication method for the improvement of dissolution rate and oral bioavailability |
| Q58692042 | Improvement of Water Solubility of Josamycin by Inclusion Complex with -Cyclodextrin |
| Q61810479 | Optimization of the Factors Affecting the Absorption of Vardenafil from Oral Disintegrating Tablets: A Clinical Pharmacokinetic Investigation |
| Q59145850 | Physicochemical Characterization and Cyclodextrin Complexation of the Anticancer Drug Lapatinib |
| Q54958449 | Polysaccharide-Based Controlled Release Systems for Therapeutics Delivery and Tissue Engineering: From Bench to Bedside. |
| Q37146180 | Preparation and evaluation of self-nanoemulsifying tablets of carvedilol. |
| Q43216548 | Preparation, optimization, and in vitro simulated inhalation delivery of carvedilol nanoparticles loaded on a coarse carrier intended for pulmonary administration |
| Q38774121 | Self-Assembly of Cyclodextrins and Their Complexes in Aqueous Solutions. |
| Q42087553 | Solid state characterization of domperidone: Hydroxypropyl-b-cyclodextrin inclusion complex |
| Q99548783 | Structural Characterization of Glycerophosphorylated and Succinylated Cyclic β-(1→2)-d-Glucan Produced by Sinorhizobium mliloti 1021 |
| Q57952990 | Structure and pharmacological studies of the anaesthetic 1-(3-n-butoxypropyl)-4-benzoyloxypiperidin hydrochloride and its complex with β-cyclodextrin in solution. NMR and IR-spectroscopy data |
Search more.